Surge2Surgery
Surge développe des solutions innovantes de prédiction des complications post-opératoires.
Niveau de maturité
- Idéation
- R&D
- Minimum viable product
- 1er client / 1ers utilisateurs
- Commercialisation
L’histoire
Surge personalizes the care of patients undergoing surgery by providing an accurate prediction of postoperative infections based on a single-cell immune system profile.
Our product predicts a patient’s risk of postoperative infections with far greater accuracy than existing clinical scales, supplying surgeons with the knowledge to guide their clinical decisions (e.g., pre-, intra-, and postoperative patient care optimization) and giving patients access to essential information about their own health.
We achieve high accuracy by using a patented AI algorithm capable of decoding the immune fingerprint obtained from a blood sample before surgery. This predictive test provides a reliable assessment of each individual’s risk of developing a postoperative infection.